We gave the indirect 5-HT agonist, D-fenfluramine (30 mg), the 5-HT antagonist methysergide (2 mg) and placebo to 11 patients with an anxiety disorder and 12 controls in a double-blind, balanced-order, cross-over design. Compared to controls, patients had significantly higher anxiety ratings, were slower in naming colours in computerized Stroop tests and showed greater interference for anxiety-related words. Patients tended to have a lower critical flicker fusion threshold (CFFT) than controls and in the subjects taken as a whole there was a significant inverse correlation between CFFT and Spielberger state (r=—0.54, p<0.01) and trait anxiety (r= - 0.55, p<0.01). Neither drug had significant effects on anxiety ratings or on Stroop interference. D- Fenfluramine significantly increased CFFT (p < 0.02) and methysergide non-significantly reduced CFFT with no significant differences between patients and controls. 5-HT may be involved in lower-level visual information processing but we found no evidence for its direct involvement in the attentional bias for anxiety- related information in the emotional Stroop.
Anderson I.M., Deakin J F W, Miller H. (1996) Effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers. Psychopharmacology128: 74-82
2.
Apostolopoulos M., Judd F.K., Burrows CD, Norman TR (1993) Prolactin response to dl-fenfluramine in panic disorder. Psychoneuroendocrinology18: 337-342
3.
Beck AT, Ward C.H., Mendelson M., Mock J.E., Erbaugh J.E. (1961) An inventory for measuring depression. Archs Gen Psychiat4: 561-567
4.
Bond AJ, Feizollah S., Lader M.H. (1995) The effects of D-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function. Psychopharmacology9:1-8
5.
Boyer W. (1995) Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmac10: 45-49
6.
Bredberg U., Eyjolfsdottir G.S., Paalzow L., Tfelt-Hansen P., Tfelt-Hansen V. (1986) Pharmacokinetics of methysergide and its metabolite methylergometrine in man. Eur J Clin Pharm30: 75-77
7.
Caccia S., Ballabio M., De Ponte P. (1979) Pharmacokinetics of fenfluramine enantiomers in man. Eur J Drug Metab Pharmacokin4:129-132
8.
Campbell D.B. (1991) Dexfenfluramine: an overview of its mechanisms of action. Rev Contemp Pharmac2: 93-113
9.
Carroll J.B., Davies P., Richman B. (1971) Word frequency book. American Heritage, New York
10.
Caycedo N., Connell J., Hellewell J S E, Deakin J F W (1994) Effect of fenfluramine on executive and other cognitive functions. J Psychopharmac (abstract book): A43
11.
Coccaro E.F., Kavoussi R.J., Oakes M., Cooper T.B., Hauger R. (1996) 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects. Psychopharmacology126: 24-30
12.
Deakin J F W, Graeff G.F. (1991) 5-HT and mechanisms of defence. J Psychopharmac5: 305-315
13.
Feeney S., Goodall E., Silverstone T. (1996) The effects of D- and L-fenfluramine (and their interactions with D-amphetamine) on psychomotor function and mood. Int Clin Psychopharmac11: 89-99
14.
Frewer L.J., Lader M. (1993) The effects of nefazodone, imipramine and placebo, alone and combined with alcohol, in normal subjects. Int Clin Psychopharmac8:13-20
15.
Garrattini S., Caccia S., Mennini T., Samanin R., Consolo S., Ladinsky H. (1979) Biochemical pharmacology of the anorectic drug fenfluramine : a review. Curr Med Res Opin6: 15-27
16.
Golombok S., Stavrou A., Bonn J., Mogg K., Critchlow S., Rust J. ( 1991) The effects of diazepam on anxiety-related cognition. Cogn Ther Res15: 459-467
17.
Goodall E.M., Cowen PJ, Franklin M., Silverstone T. (1993) Ritanserin attenuates anorectic, endocrine and thermic responses to D-fenfluramine in human volunteers. Psychopharmacology112: 461-466
18.
Hale AS, Pinninti N.R. (1995) Critical flicker fusion threshold and anticholinergic effects of chronic antidepressant treatment in remitted depressives. J Clin Psychopharmac9: 258-266
19.
Hayward P., Ahmad T., Wardle J. (1994) Into the dangerous world: an in vivo study of information processing in agoraphobics. Br J Clin Psychol33: 307-315
20.
Hindmarch I. (1994) Relevant psychometric tests for antidepressant and anxiolytics. Int Clin Psychopharmac9: 27-33
21.
Hindmarch I. (1995) The behavioural toxicity of the selective serotonin reuptake inhibitors. Int Clin Psychopharmac9:13-17
22.
Hindmarch I., Alford C., Barwell F., Kerr J.S. (1992) Measuring the side-effects of psychotropics: the behavioural toxicity of antidepressants. J Psychopharmac6: 198-203
23.
Judd F.K., Apostolopoulos M., Burrows G.D., Norman T.R. (1994) Serotonergic function in panic disorder:endocrine responses to D-fenfluramine. Prog Neuro-Psychopharmac Biol Psychiat18: 329-337
24.
Kahn R.S., Moore C. (1993) Serotonin in the pathogenesis of anxiety. In Hoehn-Saric R, McLeod D R (eds), Biology of anxiety disorders. American Psychiatric Press, Washington DC, pp. 61-102
25.
Kerr J.S., Hindmarch I. (1991) Effects of ketanserin on psychomotor performance, mood and sleep. Med Sci Res19: 493-494
26.
Kuyk T.K., Wesson M.D. (1991) Aging-related foveal flicker sensitivity losses in normal observers. Optom Vis Sci68: 786-789
27.
Lachenmayr B.J., Kojetinsky S., Ostermaier N., Angstwurm K., Vivell P M O, Schaumberger M. (1994) The different effects of aging on normal sensitivity in flicker and light-sense perimetry. Invest Opth Vis Sci35: 2741-2748
28.
MacLeod C., Hagan R. (1992) Individual differences in the selective processing of threatening information, and emotional responses to a stressful life event . Behav Res Ther30: 151-161
29.
Mathews (1993) Biases in processing emotional information. The Psychologist6: 493-499
30.
Mathews A., Klug F. ( 1993) Emotionally and interference with color-naming in anxiety . Behav Res Ther31: 57-62
31.
Mathews A., MacLeod C. (1985) Selective processing of threat cues in anxiety states. Behav Res Ther23: 563-569
32.
McEntee WJ, Crook T.H. (1991) Serotonin, memory, and the aging brain. Psychopharmacology103:143-149
33.
McNair D.M., Lorr M., Droppelman L.F. (1971) Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego, CA
34.
McNally R.J., Riemann B.C., Kim E. ( 1990) Selective processing of threat cues in panic disorder . Behav Res Ther28: 407-412
35.
McNally R.Riemann B.C., Louro C.E., Lukach B.M., Kim E. ( 1992) Cognitive processing of emotional information in panic disorder. Behav Res Ther30:143-149
36.
Mogg K., Bradley B.P., Williams R., Mathews A. (1993a) Subliminal processing of emotional information in anxiety and depression. J Abnorm Psychol102: 304-311
37.
Mogg K., Kentish J., Bradley B.P. (1993b) Effects of anxiety and awareness on colour-identification latencies for emotional words. Behav Res Ther31: 559-567
38.
Mogg K., Bradley B.P., Millar N., White J. (1995) A follow-up study of cognitive bias in generalized anxiety disorder. Behav Res Ther33: 927-935
39.
Park S.B., Coull J.T., McShane R.H., Young A.H., Sahakian B.J., Robbins T.W., Cowen PJ (1994) Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology33: 575-588
40.
Parrott A.C. (1982) Critical flicker fusion threshold and their relationship to other measures of alertness. Pharmacopsychiatria15: 49-56
41.
Peroutka S.J. (1987) Serotonin receptors. In Meltzer H Y (ed.), Psychopharmacology: the third generation of progress. Raven Press, New York , pp.303-311
42.
Pinder R.M., Rogden R.M., Sawyer P.R., Speight T.M., Avery G.S. (1975) Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs10: 241-328
43.
Rammsayer T., Netter P. (1988) Effects of changes in brain 5-HT activity on indicators of cortical arousal. Int Clin Psychopharmac3: 231-237
44.
Ramos R.T., Gentil V., Gorenstein C. (1993) Clomipramine and initial worsening in panic disorder: beyond the 'jitteriness syndrome'. J Psychopharmac7: 265-269
45.
Raven J.C. (1965) Guide to using the Mill Hill vocabulary scale with the progressive matrices scale. H.K. Lewis, London
46.
Spielberger CD, Gorsuch R.L., Lushese R.E. (1970): Manual for the state-trait anxiety inventory. Consulting Psychologists Press, Palo Alto, CA
47.
Spitzer R.L., Williams J.B., Gibbon M., First M.B. (1990) Structured clinical interview for DSM-III-R-patient edition (SCID-P, Version 1.0). American Psychiatric Press , Washington DC
48.
Steckler T., Sahgal A. (1995) The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res67: 165-199
49.
Targum S.D., Marshall L.E. (1989) Fenfluramine provocation of anxiety in patients with panic disorder. Psychiat Res28: 295-306
50.
Van Amerigen M., Mancini C., Streiner D.L. (1993) Fluoxetine efficacy in social phobia. J Clin Psychiat54: 27-32
51.
Wells A., Matthews G. (1994): Attention and emotion: a clinical perspective . Lawrence ErlbaumHillsdale, NJ
52.
Weinstein A.M., Nutt D.J. (1995) A cognitive dysfunction in anxiety and its amelioration by effective treatment with SSRIs. J Psychopharmac9: 83-89
